Ponesimod (Standard)
Ponesimod (Standard) is the analytical standard of Ponesimod. This product is intended for research and analytical applications. Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 0%
- CAS No.: 854107-55-4
- 화학식: C23H25ClN2O4S
- 분자량:460.97
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- 순도&문서
-
Help & FAQs
-
HY-10569
PonesimodS1P1 Agonist -
HY-12355
SiponimodS1P1/S1P5 Agonist -
HY-12288
OzanimodS1P Receptor Modulator -
HY-19736
TY-52156LPL Receptor Antagonist -
HY-15425
PF-543SPHK1 Inhibitor -
HY-11063
FingolimodS1P Antagonist -
HY-12005
Fingolimod hydrochlorideS1P Receptors Modulator -
HY-13822
SKI IISphK/DES1 Inhibitor -
HY-100675
JTE-013S1P2 Antagonist -
HY-10968
CYM5442S1P1 Receptor Agonist -
HY-12789
EtrasimodS1P1 Receptor Antagonist -
HY-16015
Opaganib
Product Information
Information
신청
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 854107-55-4
-
분자량 460.97
-
화학식 C23H25ClN2O4S
-
SMILES
O=C1N(C2=CC=CC=C2C)/C(S/C1=C\C3=CC=C(OC[C@H](O)CO)C(Cl)=C3)=N/CCC
-
Synonyms
ACT-128800 (Standard)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Bolli MH, et al. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. J Med Chem. 2010 May 27;53(10):4198-211. [Content Brief]
[2]. Piali L, et al. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation. J Pharmacol Exp Ther. 2011 May;337(2):547-56. [Content Brief]
[3]. Brossard P, et al. Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study. Br J Clin Pharmacol. 2013 Dec;76(6):888-96. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ponesimod (Standard) Related Classifications
HY-10569R Related Classifications
Powered by Bioz